PGC-1α, Sirtuins and PARPs in Huntington’s Disease and Other Neurodegenerative Conditions: NAD+ to Rule Them All
The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
Abstract
In this review, we summarize the available published information on the neuroprotective effects of increasing nicotinamide adenine dinucleotide (NAD+) levels in Huntington's disease models. We discuss the rationale of potential therapeutic benefit of administering nicotinamide riboside (NR), a safe and effective NAD+ precursor. We discuss the agonistic effect on the Sirtuin1-PGC-1α-PPAR pathway as well as Sirtuin 3, which converge in improving mitochondrial function, decreasing ROS production and ameliorating bioenergetics deficits. Also, we discuss the potential synergistic effect of increasing NAD+ combined with PARPs inhibitors, as a clinical therapeutic option not only in HD, but other neurodegenerative conditions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, another NAD+ precursor, NR, improves HD motor and molecular phenotypes, possibly through the activation of SIRT1-PGC-1α and SIRT3-related pathways.412”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [412]
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α
Jäger, S., Handschin, C., St.-Pierre, J., & Spiegelman, B. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705070104 · Cited by 2,491
St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jäger, S., Handschin, C., Zheng, K., Lin, J., Yang, W., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.024 · Cited by 2,233
Metabolic control through the PGC-1 family of transcription coactivators
Lin, J., Handschin, C., & Spiegelman, B. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.004 · Cited by 2,130
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
CREB regulates hepatic gluconeogenesis through the coactivator PGC-1
Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001) · Nature · doi:10.1038/35093131 · Cited by 1,440
Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation
Qiu, X., Brown, K., Hirschey, M. D., Verdin, E., & Chen, D. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.015 · Cited by 1,310
Mammalian sirtuins—emerging roles in physiology, aging, and calorie restriction
Haigis, M. C., & Guarente, L. P. (2006) · Genes & Development · doi:10.1101/gad.1467506 · Cited by 1,295
NAD + repletion improves mitochondrial and stem cell function and enhances life span in mice
Zhang, H., Ryu, D., Wu, Y., Gariani, K., Wang, X., Luan, P., D’Amico, D., Ropelle, E. R., Lutolf, M. P., Aebersold, R., et al. (2016) · Science · doi:10.1126/science.aaf2693 · Cited by 1,255
Cantó, C., Houtkooper, R. H., Pirinen, E., Youn, D. Y., Oosterveer, M. H., Cen, Y., Fernandez-Marcos, P. J., Yamamoto, H., Andreux, P. A., Cettour-Rose, P., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.022 · Cited by 1,238
New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs
Gibson, B. A., & Kraus, W. L. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3376 · Cited by 1,226
Defects in Adaptive Energy Metabolism with CNS-Linked Hyperactivity in PGC-1α Null Mice
Lin, J., Wu, P.-H., Tarr, P. T., Lindenberg, K. S., St-Pierre, J., Zhang, C.-Y., Mootha, V. K., Jäger, S., Vianna, C. R., Reznick, R. M., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.013 · Cited by 1,162
Someya, S., Yu, W., Hallows, W. C., Xu, J., Vann, J. M., Leeuwenburgh, C., Tanokura, M., Denu, J. M., & Prolla, T. A. (2010) · Cell · doi:10.1016/j.cell.2010.10.002 · Cited by 1,150
SIRT1 Functionally Interacts with the Metabolic Regulator and Transcriptional Coactivator PGC-1α
Nemoto, S., Fergusson, M. M., & Finkel, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501485200 · Cited by 1,047
Beal, M., Brouillet, E., Jenkins, B., Ferrante, R., Kowall, N., Miller, J., Storey, E., Srivastava, R., Rosen, B., & Hyman, B. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-10-04181.1993 · Cited by 1,027
Self-citationCui, L., Jeong, H., Borovecki, F., Parkhurst, C. N., Tanese, N., & Krainc, D. (2006) · Cell · doi:10.1016/j.cell.2006.09.015 · Cited by 1,012
Leone, T. C., Lehman, J. J., Finck, B. N., Schaeffer, P. J., Wende, A. R., Boudina, S., Courtois, M., Wozniak, D. F., Sambandam, N., Bernal-Mizrachi, C., et al. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030101 · Cited by 951
Nutrient-Sensitive Mitochondrial NAD+ Levels Dictate Cell Survival
Yang, H., Yang, T., Baur, J. A., Perez, E., Matsui, T., Carmona, J. J., Lamming, D. W., Souza-Pinto, N. C., Bohr, V. A., Rosenzweig, A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.07.035 · Cited by 950
Tao, R., Coleman, M. C., Pennington, J. D., Ozden, O., Park, S.-H., Jiang, H., Kim, H.-S., Flynn, C. R., Hill, S., Hayes McDonald, W., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.12.013 · Cited by 899
PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation
Bai, P., Cantó, C., Oudart, H., Brunyánszki, A., Cen, Y., Thomas, C., Yamamoto, H., Huber, A., Kiss, B., Houtkooper, R. H., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.004 · Cited by 837
Mitochondrial Dysfunction in Neurodegenerative Diseases
Johri, A., & Beal, M. F. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.192138 · Cited by 806
Self-citationHirschey, M. D., Shimazu, T., Jing, E., Grueter, C. A., Collins, A. M., Aouizerat, B., Stančáková, A., Goetzman, E., Lam, M. M., Schwer, B., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.07.019 · Cited by 787
Bieganowski, P., & Brenner, C. (2004) · Cell · doi:10.1016/s0092-8674(04)00416-7 · Cited by 750
Cytokine Stimulation of Energy Expenditure through p38 MAP Kinase Activation of PPARγ Coactivator-1
Puigserver, P., Rhee, J., Lin, J., Wu, Z., Yoon, J. C., Zhang, C.-Y., Krauss, S., Mootha, V. K., Lowell, B. B., & Spiegelman, B. M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00390-2 · Cited by 732
Handschin, C., Rhee, J., Lin, J., Tarr, P. T., & Spiegelman, B. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1232352100 · Cited by 729
Kong, X., Wang, R., Xue, Y., Liu, X., Zhang, H., Chen, Y., Fang, F., & Chang, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011707 · Cited by 718
Dominant phenotypes produced by the HD mutation in STHdhQ111 striatal cells
Trettel, F. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.19.2799 · Cited by 610
Martens, C. R., Denman, B. A., Mazzo, M. R., Armstrong, M. L., Reisdorph, N., McQueen, M. B., Chonchol, M., & Seals, D. R. (2018) · Nature Communications · doi:10.1038/s41467-018-03421-7 · Cited by 588
Fang, E. F., Kassahun, H., Croteau, D. L., Scheibye-Knudsen, M., Marosi, K., Lu, H., Shamanna, R. A., Kalyanasundaram, S., Bollineni, R. C., Wilson, M. A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.004 · Cited by 575
Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS
Chen, Y., Zhang, J., Lin, Y., Lei, Q., Guan, K., Zhao, S., & Xiong, Y. (2011) · The EMBO Reports · doi:10.1038/embor.2011.65 · Cited by 572
Weydt, P., Pineda, V. V., Torrence, A. E., Libby, R. T., Satterfield, T. F., Lazarowski, E. R., Gilbert, M. L., Morton, G. J., Bammler, T. K., Strand, A. D., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.10.004 · Cited by 562
Hafner, A. V., Dai, J., Gomes, A. P., Xiao, C.-Y., Palmeira, C. M., Rosenzweig, A., & Sinclair, D. A. (2010) · Aging · doi:10.18632/aging.100252 · Cited by 545
Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons
Parker, J. A., Arango, M., Abderrahmane, S., Lambert, E., Tourette, C., Catoire, H., & Néri, C. (2005) · Nature Genetics · doi:10.1038/ng1534 · Cited by 512
Regulation of Succinate Dehydrogenase Activity by SIRT3 in Mammalian Mitochondria
Cimen, H., Han, M.-J., Yang, Y., Tong, Q., Koc, H., & Koc, E. C. (2010) · Biochemistry · doi:10.1021/bi901627u · Cited by 477
Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson’s disease
Kam, T.-I., Mao, X., Park, H., Chou, S.-C., Karuppagounder, S. S., Umanah, G. E., Yun, S. P., Brahmachari, S., Panicker, N., Chen, R., et al. (2018) · Science · doi:10.1126/science.aat8407 · Cited by 476
Hou, Y., Lautrup, S., Cordonnier, S., Wang, Y., Croteau, D. L., Zavala, E., Zhang, Y., Moritoh, K., O’Connell, J. F., Baptiste, B. A., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718819115 · Cited by 472
Jing, E., Emanuelli, B., Hirschey, M. D., Boucher, J., Lee, K. Y., Lombard, D., Verdin, E. M., & Kahn, C. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111308108 · Cited by 469
Lerin, C., Rodgers, J. T., Kalume, D. E., Kim, S.-H., Pandey, A., & Puigserver, P. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.04.013 · Cited by 443
Tsunemi, T., Ashe, T. D., Morrison, B. E., Soriano, K. R., Au, J., Roque, R. A. V., Lazarowski, E. R., Damian, V. A., Masliah, E., & La Spada, A. R. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003799 · Cited by 442
Okamoto, S.-I., Pouladi, M. A., Talantova, M., Yao, D., Xia, P., Ehrnhoefer, D. E., Zaidi, R., Clemente, A., Kaul, M., Graham, R. K., et al. (2009) · Nature Medicine · doi:10.1038/nm.2056 · Cited by 436
OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells
Kovtun, I. V., Liu, Y., Bjoras, M., Klungland, A., Wilson, S. H., & McMurray, C. T. (2007) · Nature · doi:10.1038/nature05778 · Cited by 433
Huntingtin functions as a scaffold for selective macroautophagy
Rui, Y.-N., Xu, Z., Patel, B., Chen, Z., Chen, D., Tito, A., David, G., Sun, Y., Stimming, E. F., Bellen, H. J., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3101 · Cited by 423
Acetylation Targets Mutant Huntingtin to Autophagosomes for Degradation
Jeong, H., Then, F., Melia, T. J., Mazzulli, J. R., Cui, L., Savas, J. N., Voisine, C., Paganetti, P., Tanese, N., Hart, A. C., et al. (2009) · Cell · doi:10.1016/j.cell.2009.03.018 · Cited by 419
Belenky, P., Racette, F. G., Bogan, K. L., McClure, J. M., Smith, J. S., & Brenner, C. (2007) · Cell · doi:10.1016/j.cell.2007.03.024 · Cited by 411
Green, K. N., Steffan, J. S., Martinez-Coria, H., Sun, X., Schreiber, S. S., Thompson, L. M., & LaFerla, F. M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3203-08.2008 · Cited by 404
Involvement of PGC-1α in the formation and maintenance of neuronal dendritic spines
Cheng, A., Wan, R., Yang, J.-L., Kamimura, N., Son, T. G., Ouyang, X., Luo, Y., Okun, E., & Mattson, M. P. (2012) · Nature Communications · doi:10.1038/ncomms2238 · Cited by 401
NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells
Ratajczak, J., Joffraud, M., Trammell, S. A. J., Ras, R., Canela, N., Boutant, M., Kulkarni, S. S., Rodrigues, M., Redpath, P., Migaud, M. E., et al. (2016) · Nature Communications · doi:10.1038/ncomms13103 · Cited by 378
Mitochondrial and Nuclear Cross Talk in Cell Death: Parthanatos
Andrabi, S. A., Dawson, T. M., & Dawson, V. L. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.014 · Cited by 376
Cheng, A., Yang, Y., Zhou, Y., Maharana, C., Lu, D., Peng, W., Liu, Y., Wan, R., Marosi, K., Misiak, M., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.10.013 · Cited by 371
Bellizzi, D., Rose, G., Cavalcante, P., Covello, G., Dato, S., De Rango, F., Greco, V., Maggiolini, M., Feraco, E., Mari, V., et al. (2005) · Genomics · doi:10.1016/j.ygeno.2004.11.003 · Cited by 367
Jeong, H., Cohen, D. E., Cui, L., Supinski, A., Savas, J. N., Mazzulli, J. R., Yates, J. R., Bordone, L., Guarente, L., & Krainc, D. (2012) · Nature Medicine · doi:10.1038/nm.2559 · Cited by 367
Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease
Kim, J., Moody, J. P., Edgerly, C. K., Bordiuk, O. L., Cormier, K., Smith, K., Beal, M. F., & Ferrante, R. J. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq306 · Cited by 357
Self-citationJiang, M., Wang, J., Fu, J., Du, L., Jeong, H., West, T., Xiang, L., Peng, Q., Hou, Z., Cai, H., et al. (2012) · Nature Medicine · doi:10.1038/nm.2558 · Cited by 345
Gong, B., Pan, Y., Vempati, P., Zhao, W., Knable, L., Ho, L., Wang, J., Sastre, M., Ono, K., Sauve, A. A., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.12.005 · Cited by 345
Schöndorf, D. C., Ivanyuk, D., Baden, P., Sanchez-Martinez, A., De Cicco, S., Yu, C., Giunta, I., Schwarz, L. K., Di Napoli, G., Panagiotakopoulou, V., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.009 · Cited by 337
Swami, M., Hendricks, A. E., Gillis, T., Massood, T., Mysore, J., Myers, R. H., & Wheeler, V. C. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp242 · Cited by 327
Gu, X., Greiner, E. R., Mishra, R., Kodali, R., Osmand, A., Finkbeiner, S., Steffan, J. S., Thompson, L. M., Wetzel, R., & Yang, X. W. (2009) · Neuron · doi:10.1016/j.neuron.2009.11.020 · Cited by 323
Oxidative Damage in Huntington's Disease Pathogenesis
Browne, S. E., & Beal, M. F. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.2061 · Cited by 310
Self-citationWeissman, L., Jo, D.-G., Sorensen, M. M., de Souza-Pinto, N. C., Markesbery, W. R., Mattson, M. P., & Bohr, V. A. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm605 · Cited by 299
PGC-1α and PGC-1Β Regulate Mitochondrial Density in Neurons
Wareski, P., Vaarmann, A., Choubey, V., Safiulina, D., Liiv, J., Kuum, M., & Kaasik, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.018911 · Cited by 294
Wu, Z., Huang, X., Feng, Y., Handschin, C., Feng, Y., Gullicksen, P. S., Bare, O., Labow, M., Spiegelman, B., & Stevenson, S. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606714103 · Cited by 291
Brown, K. D., Maqsood, S., Huang, J.-Y., Pan, Y., Harkcom, W., Li, W., Sauve, A., Verdin, E., & Jaffrey, S. R. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.11.003 · Cited by 277
Niacin in the Central Nervous System: An Update of Biological Aspects and Clinical Applications
Gasperi, V., Sibilano, M., Savini, I., & Catani, M. V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040974 · Cited by 277
XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia
Care4Rare Canada Consortium, Hoch, N. C., Hanzlikova, H., Rulten, S. L., Tétreault, M., Komulainen, E., Ju, L., Hornyak, P., Zeng, Z., Gittens, W., et al. (2017) · Nature · doi:10.1038/nature20790 · Cited by 269
Pallos, J., Bodai, L., Lukacsovich, T., Purcell, J. M., Steffan, J. S., Thompson, L. M., & Marsh, J. L. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn273 · Cited by 265
p38 Mitogen-activated Protein Kinase Activates Peroxisome Proliferator-activated Receptor α
Barger, P. M., Browning, A. C., Garner, A. N., & Kelly, D. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105945200 · Cited by 260
Gibson, G. E., Starkov, A., Blass, J. P., Ratan, R. R., & Beal, M. F. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.010 · Cited by 256
Self-citationPARP-2 Regulates SIRT1 Expression and Whole-Body Energy Expenditure
Bai, P., Canto, C., Brunyánszki, A., Huber, A., Szántó, M., Cen, Y., Yamamoto, H., Houten, S. M., Kiss, B., Oudart, H., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.013 · Cited by 251
Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease
Bogdanov, M. B., Andreassen, O. A., Dedeoglu, A., Ferrante, R. J., & Beal, M. F. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00689.x · Cited by 248
Self-citationCrosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes
Cantó, C., Sauve, A. A., & Bai, P. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.01.004 · Cited by 246
Dragileva, E., Hendricks, A., Teed, A., Gillis, T., Lopez, E. T., Friedberg, E. C., Kucherlapati, R., Edelmann, W., Lunetta, K. L., MacDonald, M. E., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.09.014 · Cited by 246
PGC-1β in the Regulation of Hepatic Glucose and Energy Metabolism
Lin, J., Tarr, P. T., Yang, R., Rhee, J., Puigserver, P., Newgard, C. B., & Spiegelman, B. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303643200 · Cited by 242
Impaired PGC-1α function in muscle in Huntington's disease
Chaturvedi, R. K., Adhihetty, P., Shukla, S., Hennessy, T., Calingasan, N., Yang, L., Starkov, A., Kiaei, M., Cannella, M., Sassone, J., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp243 · Cited by 235
Self-citationBase excision repair of oxidative DNA damage from mechanism to disease
Freudenthal, B. D. (2017) · Frontiers in Bioscience · doi:10.2741/4555 · Cited by 230
Chen, C.-M., Wu, Y.-R., Cheng, M.-L., Liu, J.-L., Lee, Y.-M., Lee, P.-W., Soong, B.-W., & Chiu, D. T.-Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.093 · Cited by 228
Fu, J., Jin, J., Cichewicz, R. H., Hageman, S. A., Ellis, T. K., Xiang, L., Peng, Q., Jiang, M., Arbez, N., Hotaling, K., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.382226 · Cited by 210
For the European Huntington Disease Network, Weydt, P., Soyal, S. M., Landwehrmeyer, G. B., & Patsch, W. (2014) · BMC Neurology · doi:10.1186/1471-2377-14-1 · Cited by 206
An overview of Sirtuins as potential therapeutic target: Structure, function and modulators
Wang, Y., He, J., Liao, M., Hu, M., Li, W., Ouyang, H., Wang, X., Ye, T., Zhang, Y., & Ouyang, L. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.10.028 · Cited by 202
SIRT3 deficiency impairs mitochondrial and contractile function in the heart
Koentges, C., Pfeil, K., Schnick, T., Wiese, S., Dahlbock, R., Cimolai, M. C., Meyer-Steenbuck, M., Cenkerova, K., Hoffmann, M. M., Jaeger, C., et al. (2015) · Basic Research in Cardiology · doi:10.1007/s00395-015-0493-6 · Cited by 200
The Influence of Nicotinamide on Health and Disease in the Central Nervous System
Fricker, R. A., Green, E. L., Jenkins, S. I., & Griffin, S. M. (2018) · International Journal of Tryptophan Research · doi:10.1177/1178646918776658 · Cited by 200
Gametic but not somatic instability of CAG repeat length in Huntington's disease.
MacDonald, M. E., Barnes, G., Srinidhi, J., Duyao, M. P., Ambrose, C. M., Myers, R. H., Gray, J., Conneally, P. M., Young, A., & Penney, J. (1993) · Journal of Medical Genetics · doi:10.1136/jmg.30.12.982 · Cited by 194
Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate
Beal, M. F., Henshaw, D. R., Jenkins, B. G., Rosen, B. R., & Schulz, J. B. (1994) · Annals of Neurology · doi:10.1002/ana.410360613 · Cited by 189
Self-citationDellinger, R. W., Santos, S. R., Morris, M., Evans, M., Alminana, D., Guarente, L., & Marcotulli, E. (2017) · npj Aging and Mechanisms of Disease · doi:10.1038/s41514-017-0016-9 · Cited by 181
Süssmuth, S. D., Haider, S., Landwehrmeyer, G. B., Farmer, R., Frost, C., Tripepi, G., Andersen, C. A., Di Bacco, M., Lamanna, C., Diodato, E., et al. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12512 · Cited by 175
Nicotinamide is an inhibitor of SIRT1 in vitro, but can be a stimulator in cells
Hwang, E. S., & Song, S. B. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2527-8 · Cited by 174
Neuronal Sirt3 Protects against Excitotoxic Injury in Mouse Cortical Neuron Culture
Kim, S. H., Lu, H. F., & Alano, C. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014731 · Cited by 163
Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease
Ho, D. J., Calingasan, N. Y., Wille, E. J., Dumont, M., & Beal, M. F. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.05.006 · Cited by 160
Self-citationJohri, A., Calingasan, N. Y., Hennessey, T. M., Sharma, A., Yang, L., Wille, E., Chandra, A., & Beal, M. F. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr541 · Cited by 158
Self-citationSmith, M. R., Syed, A., Lukacsovich, T., Purcell, J., Barbaro, B. A., Worthge, S. A., Wei, S. R., Pollio, G., Magnoni, L., Scali, C., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu010 · Cited by 151
Goula, A.-V., Berquist, B. R., Wilson, D. M., Wheeler, V. C., Trottier, Y., & Merienne, K. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000749 · Cited by 144
Naia, L., Rosenstock, T. R., Oliveira, A. M., Oliveira-Sousa, S. I., Caldeira, G. L., Carmo, C., Laço, M., Hayden, M. R., Oliveira, C. R., & Rego, A. C. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0048-3 · Cited by 143
Role of oxidative DNA damage in mitochondrial dysfunction and Huntington’s disease pathogenesis
Ayala-Peña, S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.04.017 · Cited by 141
Exosomes from adipose‐derived stem cells ameliorate phenotype of Huntington's disease in vitro model
Lee, M., Liu, T., Im, W., & Kim, M. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13275 · Cited by 141
Brain-Derived Neurotrophic Factor in Patients with Huntington's Disease
Zuccato, C., Marullo, M., Vitali, B., Tarditi, A., Mariotti, C., Valenza, M., Lahiri, N., Wild, E. J., Sassone, J., Ciammola, A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022966 · Cited by 138
Chen, T., Liu, J., Li, N., Wang, S., Liu, H., Li, J., Zhang, Y., & Bu, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118909 · Cited by 136
DNA polymerase β deficiency leads to neurodegeneration and exacerbates Alzheimer disease phenotypes
Sykora, P., Misiak, M., Wang, Y., Ghosh, S., Leandro, G. S., Liu, D., Tian, J., Baptiste, B. A., Cong, W.-N., Brenerman, B. M., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1356 · Cited by 136
Localization of sequence variations in PGC-1α influence their modifying effect in Huntington disease
Che, H. V. B., Metzger, S., Portal, E., Deyle, C., Riess, O., & Nguyen, H. P. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-1 · Cited by 136
Taherzadeh-Fard, E., Saft, C., Akkad, D. A., Wieczorek, S., Haghikia, A., Chan, A., Epplen, J. T., & Arning, L. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-32 · Cited by 134
Chaturvedi, R. K., Calingasan, N. Y., Yang, L., Hennessey, T., Johri, A., & Beal, M. F. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq229 · Cited by 134
Self-citationXiang, Z., Valenza, M., Cui, L., Leoni, V., Jeong, H.-K., Brilli, E., Zhang, J., Peng, Q., Duan, W., Reeves, S. A., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1291-11.2011 · Cited by 132
Pharmacological Effects of Exogenous NAD on Mitochondrial Bioenergetics, DNA Repair, and Apoptosis
Pittelli, M. G., Felici, R., Pitozzi, V., Giovannelli, L., Bigagli, E., Cialdai, F., Romano, G., Moroni, F., & Chiarugi, A. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.073916 · Cited by 132
Cdc2-like Kinase 2 Is an Insulin-Regulated Suppressor of Hepatic Gluconeogenesis
Rodgers, J. T., Haas, W., Gygi, S. P., & Puigserver, P. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2009.11.006 · Cited by 129
Modulation of SIRT1 expression in different neurodegenerative models and human pathologies
Pallàs, M., Pizarro, J. G., Cuesta, J., Crespo‐Biel, N., Alvira, D., Tajes, M., Yeste‐Velasco, M., Folch, J., Canudas, A. M., Sureda, F. X., et al. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.04.065 · Cited by 123
Hathorn, T., Snyder-Keller, A., & Messer, A. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.08.017 · Cited by 123
Huntingtin is a scaffolding protein in the ATM oxidative DNA damage response complex
Maiuri, T., Mocle, A. J., Hung, C. L., Xia, J., van Roon-Mom, W. M. C., & Truant, R. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw395 · Cited by 119
Sirtuins in Neuroendocrine Regulation and Neurological Diseases
Fujita, Y., & Yamashita, T. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00778 · Cited by 119
Yang, T., Chan, N. Y.-K., & Sauve, A. A. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm701001c · Cited by 117
Expression pattern of apoptosis-related markers in Huntington’s disease
Vis, J. C., Schipper, E. E., Huizen, R. D. B.-V., Verbeek, M. M., de Waal, R. M. W., Wesseling, P., ten Donkelaar, H. J., & Kremer, B. H. P. H. (2005) · Acta Neuropathologica · doi:10.1007/s00401-004-0957-5 · Cited by 117
Wang, S., Xing, Z., Vosler, P. S., Yin, H., Li, W., Zhang, F., Signore, A. P., Stetler, R. A., Gao, Y., & Chen, J. (2008) · Stroke · doi:10.1161/strokeaha.107.509158 · Cited by 117
Coordination between Polymerase β and FEN1 Can Modulate CAG Repeat Expansion
Liu, Y., Prasad, R., Beard, W. A., Hou, E. W., Horton, J. K., McMurray, C. T., & Wilson, S. H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.050286 · Cited by 115
DNA Polymerase Beta Participates in Mitochondrial DNA Repair
Sýkora, P., Kanno, S.-I., Akbari, M., Kulikowicz, T., Baptiste, B. A., Leandro, G. D. S., Lu, H., Tian, J. Y., May, A., Becker, K. A., et al. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00237-17 · Cited by 115
Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis
McGurk, L., Mojsilovic-Petrovic, J., Van Deerlin, V. M., Shorter, J., Kalb, R. G., Lee, V. M., Trojanowski, J. Q., Lee, E. B., & Bonini, N. M. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0586-1 · Cited by 114
Mitochondrial regulation of cell death: a phylogenetically conserved control
Galluzzi, L., Kepp, O., & Kroemer, G. (2016) · Microbial Cell · doi:10.15698/mic2016.03.483 · Cited by 105
Hands, S., Sajjad, M. U., Newton, M. J., & Wyttenbach, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.307587 · Cited by 103
PARP-1 Inhibition Is Neuroprotective in the R6/2 Mouse Model of Huntington’s Disease
Cardinale, A., Paldino, E., Giampà, C., Bernardi, G., & Fusco, F. R. (2015) · PLOS ONE · doi:10.1371/journal.pone.0134482 · Cited by 103
Zhong, N., & Xu, J. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn230 · Cited by 99
Andreassen, O. A., Dedeoglu, A., Friedlich, A., Ferrante, K. L., Hughes, D., Szabo, C., & Beal, M. F. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7633 · Cited by 96
Self-citationBirkmayer, J. G. D., Vrecko, C., Volc, D., & Birkmayer, W. (1993) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1993.tb00018.x · Cited by 94
Harlan, B. A., Pehar, M., Sharma, D. R., Beeson, G., Beeson, C. C., & Vargas, M. R. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.698779 · Cited by 94
Safety assessment of nicotinamide riboside, a form of vitamin B3
Conze, D., Crespo-Barreto, J., & Kruger, C. (2016) · Human & Experimental Toxicology · doi:10.1177/0960327115626254 · Cited by 93
Soyal, S. M., Felder, T. K., Auer, S., Hahne, P., Oberkofler, H., Witting, A., Paulmichl, M., Landwehrmeyer, G. B., Weydt, P., Patsch, W., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds177 · Cited by 92
Vaur, P., Brugg, B., Mericskay, M., Li, Z., Schmidt, M. S., Vivien, D., Orset, C., Jacotot, E., Brenner, C., & Duplus, E. (2017) · The FASEB Journal · doi:10.1096/fj.201700221rr · Cited by 86
Outeiro, T. F., Grammatopoulos, T. N., Altmann, S., Amore, A. M., Standaert, D. G., Hyman, B. T., & Kazantsev, A. G. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.163 · Cited by 84
Cellular bioenergetics is regulated by PARP1 under resting conditions and during oxidative stress
Módis, K., Gerő, D., Erdélyi, K., Szoleczky, P., DeWitt, D., & Szabo, C. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.014 · Cited by 81
Huang, Q., Sun, M., Li, M., Zhang, D., Han, F., Wu, J., Fukunaga, K., Chen, Z., & Qin, Z.-H. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0809-7 · Cited by 76
DNA polymerase β: A missing link of the base excision repair machinery in mammalian mitochondria
Prasad, R., Çağlayan, M., Dai, D., Nadalutti, C. A., Zhao, M., Gassman, N. R., Janoshazi, A. K., Stefanick, D. F., Horton, J. K., Krasich, R., et al. (2017) · DNA repair · doi:10.1016/j.dnarep.2017.10.011 · Cited by 74
Podvin, S., Reardon, H. T., Yin, K., Mosier, C., & HOOK, V. Y. H. (2018) · Journal of Neurology · doi:10.1007/s00415-018-8940-6 · Cited by 71
Lehmann, S., Costa, A. C., Celardo, I., Loh, S. H. Y., & Martins, L. M. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.72 · Cited by 69
DiGiovanni, L. F., Mocle, A. J., Xia, J., & Truant, R. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw234 · Cited by 64
Westerberg, G., Chiesa, J., Andersen, C. A. F., Diamanti, D., Magnoni, L., Pollio, G., Darpö, B., & Zhou, M. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12513 · Cited by 63
Martire, S., Fuso, A., Mosca, L., Forte, E., Correani, V., Fontana, M., Scarpa, S., Maras, B., & d’Erme, M. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-151040 · Cited by 63
Effects of chronic MPTP and 3-nitropropionic acid in nonhuman primates
Brouillet, E., & Hantraye, P. (1995) · Current Opinion in Neurology · doi:10.1097/00019052-199512000-00014 · Cited by 62
Martin, E., Bétuing, S., Pagès, C., Cambon, K., Aurégan, G., Déglon, N., Roze, E. F., & Caboche, J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr148 · Cited by 61
Integration of β-Catenin, Sirtuin, and FOXO Signaling Protects from Mutant Huntingtin Toxicity
Parker, J. A., Vazquez-Manrique, R. P., Tourette, C., Farina, F., Offner, N., Mukhopadhyay, A., Orfila, A.-M., Darbois, A., Menet, S., Tissenbaum, H. A., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0277-12.2012 · Cited by 60
Huntington’s disease: the coming of age
Pandey, M., & Rajamma, U. (2018) · Journal of Genetics · doi:10.1007/s12041-018-0957-1 · Cited by 59
Akie, T. E., Liu, L., Nam, M., Lei, S., & Cooper, M. P. (2015) · PLOS ONE · doi:10.1371/journal.pone.0125617 · Cited by 56
Askeland, G., Dosoudilova, Z., Rodinova, M., Klempir, J., Liskova, I., Kuśnierczyk, A., Bjørås, M., Nesse, G., Klungland, A., Hansikova, H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-27985-y · Cited by 54
Vijayvargia, R., Epand, R., Leitner, A., Jung, T.-Y., Shin, B., Jung, R., Lloret, A., Singh Atwal, R., Lee, H., Lee, J.-M., et al. (2016) · eLife · doi:10.7554/elife.11184 · Cited by 52
Self-citationPhase II Clinical Trial of Nicotinamide for the Treatment of Mild to Moderate Alzheimer's Disease
Phelan, M. J. (2017) · Journal of Geriatric Medicine and Gerontology · doi:10.23937/2469-5858/1510021 · Cited by 52
Oláh, G., Szczesny, B., Brunyánszki, A., López-García, I. A., Gerö, D., Radák, Z., & Szabo, C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0134227 · Cited by 51
Misiak, M., Vergara Greeno, R., Baptiste, B. A., Sykora, P., Liu, D., Cordonnier, S., Fang, E. F., Croteau, D. L., Mattson, M. P., & Bohr, V. A. (2017) · Aging Cell · doi:10.1111/acel.12541 · Cited by 50
Jędrak, P., Mozolewski, P., Węgrzyn, G., & Więckowski, M. R. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0308-1 · Cited by 50
Vijayvargia, R., Epand, R. F., Leitner, A., Jung, T., Shin, B., Jung, R., Lloret, A., Atwal, R. S., Lee, H., Lee, J., et al. (2016) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-b-000114979 · Cited by 48
Self-citationNo evidence for cognitive improvement from oral nicotinamide adenine dinucleotide (NADH) in dementia
Rainer, M., Kraxberger, E., Haushofer, M., Mucke, H. A. M., & Jellinger, K. A. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070011 · Cited by 46
Lee, M., Ban, J.-J., Chung, J. Y., Im, W., & Kim, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195968 · Cited by 44
Leung, A. K. L. (2017) · Current Biology · doi:10.1016/j.cub.2017.09.054 · Cited by 44
López Castel, A., Tomkinson, A. E., & Pearson, C. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.034405 · Cited by 43
Goula, A.-V., Pearson, C. E., Della-Maria, J., Trottier, Y., Tomkinson, A. E., Wilson, D. M., & Mérienne, K. (2012) · Biochemistry · doi:10.1021/bi300410d · Cited by 43
Genetic models of PGC-1 and glucose metabolism and homeostasis
Rowe, G. C., & Arany, Z. P. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9273-5 · Cited by 43
Tulino, R., Benjamin, A. C., Jolinon, N., Smith, D. L., Chini, E. N., Carnemolla, A., & Bates, G. P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145425 · Cited by 42
Hung, C. L.-K., Maiuri, T., Bowie, L. E., Gotesman, R., Son, S., Falcone, M., Giordano, J. V., Gillis, T., Mattis, V., Lau, T., et al. (2018) · Molecular Biology of the Cell · doi:10.1091/mbc.e18-09-0590 · Cited by 42
Prospects for neuroprotective therapies in prodromal Huntington's disease
Chandra, A., Johri, A., & Beal, M. F. (2014) · Movement Disorders · doi:10.1002/mds.25835 · Cited by 41
Self-citationMetabolic aspects of neuronal degeneration: From a NAD+ point of view
Sasaki, Y. (2018) · Neuroscience Research · doi:10.1016/j.neures.2018.07.001 · Cited by 39
Alisky, J. M. (2005) · Nutritional Neuroscience · doi:10.1080/10284150500484638 · Cited by 38
Paldino, E., Cardinale, A., D’Angelo, V., Sauve, I., Giampà, C., & Fusco, F. R. (2017) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2017.00061 · Cited by 38
The emergence of the nicotinamide riboside kinases in the regulation of NAD+ metabolism
Fletcher, R. S., & Lavery, G. G. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0085 · Cited by 38
Sidhu, A., Diwan, V., Kaur, H., Bhateja, D., Singh, C. K., Sharma, S., & Padi, S. S. V. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0297-0 · Cited by 34
Integrin-Dependent Akt1 Activation Regulates PGC-1 Expression and Fatty Acid Oxidation
Beeson, C., Beeson, G. C., Buff, H., Eldridge, J. D., Zhang, A., Seth, A. K., Demcheva, M. V., Vournakis, J. N., & Muise‐Helmericks, R. C. (2012) · Journal of Vascular Research · doi:10.1159/000332326 · Cited by 25
Is NADH Effective in the Treatment of Parkinson??s Disease?
Swerdlow, R. H. (1998) · Drugs & Aging · doi:10.2165/00002512-199813040-00002 · Cited by 24
Birkmayer, W., Birkmayer, G. J. D., Vrecko, K., Mlekusch, W., Paletta, B., & Ott, E. (1989) · Journal of Neural Transmission - Parkinson's Disease and Dementia Section · doi:10.1007/bf02263483 · Cited by 23
Askeland, G., Rodinová, M., Štufková, H., Dosoudilova, Z., Baxa, M., Šmatlíková, P., Bohuslavová, B., Klempíř, J., Nguyen, T. D., Kuśnierczyk, A., et al. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.035949 · Cited by 21
Treatment of Parkinson's disease with NADH
Dizdar, N., Kågedal, B., & Lindvall, B. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1994.tb02735.x · Cited by 20
Tulino, R., Benjamin, A. C., Jolinon, N., Smith, D. L., Chini, E. N., Carnemolla, A., & Bates, G. P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150682 · Cited by 20
Birkmayer, W., Birkmayer, J. G. D., Vrečko, K., & Paletta, B. (1990) · PubMed · Cited by 15
Reilmann, R., Squitieri, F., Priller, J., Carsten Saft, C., Mariotti, C., Süßmuth, S. D., Nemeth, A. H., Tabrizi, S. J., Quarrell, O. W. J., Craufurd, D., et al. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309032.294 · Cited by 14
Metzger, S., Che, H. V., Deyle, C., Riess, O., & Nguyen, H. P. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.222588.7 · Cited by 8
Research works printed but not linked: 1
- Handschin C, Rhee J, Lin J, Tarr PT, Spiegelman BM (2003) An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle. Proc Natl Acad Sci U S A 100:7111–7116 · DOI · Paper page
Cited by
NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential
Xie, N., Zhang, L., Gao, W., Huang, C., Huber, P. E., Zhou, X., Li, C., Shen, G., & Zou, B. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00311-7 · Cited by 1,052
NAD+ in Brain Aging and Neurodegenerative Disorders
Lautrup, S., Sinclair, D. A., Mattson, M. P., & Fang, E. F. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.09.001 · Cited by 790
“In addition to themodulation of the kynurenine pathway, direct supplementation with NAD+ precursors as well as an agonistic augmentation of the NAD+/SIRT1-PGC-1a axis and SIRT3 activity show therapeutic potential for HD (Lloret and Beal, 2019).”
InfluentialRole of NAD+ in regulating cellular and metabolic signaling pathways
Amjad, S., Nisar, S., Bhat, A. A., Shah, A. R., Frenneaux, M. P., Fakhro, K., Haris, M., Reddy, R., Patay, Z., Baur, J., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101195 · Cited by 384
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
NAD metabolism: Role in senescence regulation and aging
Chini, C. C. S., Cordeiro, H. S., Tran, N. L. K., & Chini, E. N. (2023) · Aging Cell · doi:10.1111/acel.13920 · Cited by 167
“Activation of the NAD + /SIRT1- PGC-1 α axis has been shown to be dysregulated in neurodegenerative diseases, such as Huntington's disease (Lloret & Beal, 2019), amyotrophic lateral sclerosis (Herskovits et al., 2018; Kim et al., 2007), and in accelerated aging pathologies such as Cockayne syndrome…”
Background
Metadata
- Authors
- Lloret, A., & Beal, M. F.
- Affiliations
- Weill Cornell Medicine (US)
- Corresponding author
- Lloret, Alejandro
- ORCID
- Lloret, Alejandro
- Venue
- Neurochemical Research
- Published
- 2019-05-07
- Volume
- 44
- Issue
- 10
- Pages
- 2423-2434
- ISSN
- 0364-3190 (ISSN-L)
- 1573-6903
- OpenAlex
- W2944287087
- Cited by
- 52
- References
- 171
- Citations by year
- 2026: 3 · 2025: 14 · 2024: 8 · 2023: 8 · 2022: 5 · 2021: 6 · 2020: 6 · 2019: 2
- FWCI
- 0.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Neurochemical Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- NINDS (5R01NS086746-04)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Huntington's disease, NAD+, nicotinamide riboside, sirtuins, SIRT1, PGC-1α, peroxisome proliferator-activated receptors, SIRT3, PARP inhibitors, mitochondrial function, reactive oxygen species, bioenergetics, neuroprotection, neurodegenerative diseases
- MeSH terms
- Poly (ADP-Ribose) Polymerase-1, Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Animals, Humans, Mitochondria, NAD, Neurodegenerative Diseases, Sirtuins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.